Lidocaine - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for lidocaine and what is the scope of freedom to operate?
Lidocaine
is the generic ingredient in forty-five branded drugs marketed by Astrazeneca, Noven, Carlisle, Aleor Dermaceuticals, Alkem Labs Ltd, Amneal Pharms, Belmora Llc, Cosette, Dr Reddys, Fougera Pharms Inc, Geneyork Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Pai Holdings Pharm, Quagen, Rising, Septodont Inc, Strides Pharma, Taro, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Amneal, Mylan Technologies, Nal Pharm, Noven Pharms Inc, Rhodes Pharms, Teikoku Pharma Usa, Scilex Pharms, Thea Pharma, Abbott, Abraxis Pharm, Afaxys, Akorn, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Dell Labs, Elkins Sinn, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Miles, Sintetica Us, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Mylan Labs Ltd, Pharmaton, Meridian Medcl Techn, Dentsply Pharm, Bionpharma Inc, Sagent Pharms Inc, Watson Labs Inc, Wockhardt Bio Ag, Actavis Mid Atlantic, Lannett Co Inc, Hikma, Kendall Il, Novitium Pharma, Paco, Powder Pharms, Pfizer, Teva Branded Pharm, Fougera Pharms, Padagis Us, Tolmar, Taro Pharms, and Galen Specialty, and is included in one hundred and fifty-four NDAs. There are thirteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Lidocaine has thirty-seven patent family members in eighteen countries.
There are twenty-nine drug master file entries for lidocaine. Forty-five suppliers are listed for this compound.
Summary for lidocaine
International Patents: | 37 |
US Patents: | 13 |
Tradenames: | 45 |
Applicants: | 78 |
NDAs: | 154 |
Drug Master File Entries: | 29 |
Finished Product Suppliers / Packagers: | 45 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 1,716 |
Patent Applications: | 7,046 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for lidocaine |
Drug Sales Revenues: | Drug sales revenues for lidocaine |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for lidocaine |
What excipients (inactive ingredients) are in lidocaine? | lidocaine excipients list |
DailyMed Link: | lidocaine at DailyMed |
Recent Clinical Trials for lidocaine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GCS Ramsay Santé pour l'Enseignement et la Recherche | N/A |
St. Louis University | Phase 4 |
AbbVie | Phase 4 |
Pharmacology for lidocaine
Drug Class | Amide Local Anesthetic Antiarrhythmic |
Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for lidocaine
US Patents and Regulatory Information for lidocaine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quagen | LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 212695-001 | Apr 20, 2021 | AT | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Rising | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 091058-001 | Sep 30, 2010 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Dentsply Pharm | XYLOCAINE DENTAL | lidocaine hydrochloride | INJECTABLE;INJECTION | 021380-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lidocaine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Noven | DENTIPATCH | lidocaine | PATCH;TOPICAL | 020575-002 | May 21, 1996 | See Plans and Pricing | See Plans and Pricing |
Noven | DENTIPATCH | lidocaine | FILM, EXTENDED RELEASE;BUCCAL | 020575-001 | May 21, 1996 | See Plans and Pricing | See Plans and Pricing |
Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for lidocaine
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | WO2013046335 | 非水性貼付剤 | See Plans and Pricing |
Portugal | 2823815 | See Plans and Pricing | |
Japan | 6021269 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.